![]() |
Name |
Chaetominine
|
Molecular Formula | C22H18N4O4 | |
IUPAC Name* |
(1S,10S,13R,15S)-1-hydroxy-10-methyl-13-(4-oxoquinazolin-3-yl)-8,11-diazatetracyclo[6.6.1.02,7.011,15]pentadeca-2,4,6-triene-9,12-dione
|
|
SMILES |
C[C@H]1C(=O)N2[C@@H]3N1C(=O)[C@@H](C[C@@]3(C4=CC=CC=C42)O)N5C=NC6=CC=CC=C6C5=O
|
|
InChI |
InChI=1S/C22H18N4O4/c1-12-18(27)26-16-9-5-3-7-14(16)22(30)10-17(20(29)25(12)21(22)26)24-11-23-15-8-4-2-6-13(15)19(24)28/h2-9,11-12,17,21,30H,10H2,1H3/t12-,17+,21-,22-/m0/s1
|
|
InChIKey |
GEURDGODABUDHB-TYTLQBBQSA-N
|
|
Synonyms |
Chaetominine; 918659-56-0; (2S,4R,5aS,9cS)-5a-hydroxy-2-methyl-4-(4-oxoquinazolin-3(4H)-yl)-4,5,5a,9c-tetrahydro-3H-2a,9b-diazacyclopenta[jk]fluorene-1,3(2H)-dione; (2S,2a1S,4R,5aS)-5a-hydroxy-2-methyl-4-(4-oxoquinazolin-3(4H)-yl)-2a1,4,5,5a-tetrahydro-1H-2a,9b-diazacyclopenta[jk]fluorene-1,3(2H)-dione; chaetomimine; (-)-Chaetominine; CHEBI:65610; DTXSID80582495; NSC746369; ZINC14922716; NSC-746369; HY-125136; CS-0089447; J-501045; Q27134076; (1S,10S,13R,15S)-1-hydroxy-10-methyl-13-(4-oxoquinazolin-3-yl)-8,11-diazatetracyclo[6.6.1.02,7.011,15]pentadeca-2,4,6-triene-9,12-dione; (2S,4R,5as,9cs)-4,5,5a,9c-tetrahydro-5a-hydroxy-2-methyl-4-(4-oxo-3(4h)-quinazolinyl)-3h-2a,9b-diazacyclopenta(jk)fluorene-1,3(2h)-d ione
|
|
CAS | 918659-56-0 | |
PubChem CID | 16095273 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 402.4 | ALogp: | 0.8 |
HBD: | 1 | HBA: | 5 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 93.5 | Aromatic Rings: | 6 |
Heavy Atoms: | 30 | QED Weighted: | 0.667 |
Caco-2 Permeability: | -5.283 | MDCK Permeability: | 0.00005300 |
Pgp-inhibitor: | 0.143 | Pgp-substrate: | 0.006 |
Human Intestinal Absorption (HIA): | 0.018 | 20% Bioavailability (F20%): | 0.011 |
30% Bioavailability (F30%): | 0.175 |
Blood-Brain-Barrier Penetration (BBB): | 0.087 | Plasma Protein Binding (PPB): | 71.93% |
Volume Distribution (VD): | 0.914 | Fu: | 37.74% |
CYP1A2-inhibitor: | 0.021 | CYP1A2-substrate: | 0.357 |
CYP2C19-inhibitor: | 0.104 | CYP2C19-substrate: | 0.646 |
CYP2C9-inhibitor: | 0.197 | CYP2C9-substrate: | 0.824 |
CYP2D6-inhibitor: | 0.007 | CYP2D6-substrate: | 0.105 |
CYP3A4-inhibitor: | 0.333 | CYP3A4-substrate: | 0.929 |
Clearance (CL): | 4.609 | Half-life (T1/2): | 0.18 |
hERG Blockers: | 0.004 | Human Hepatotoxicity (H-HT): | 0.886 |
Drug-inuced Liver Injury (DILI): | 0.993 | AMES Toxicity: | 0.012 |
Rat Oral Acute Toxicity: | 0.398 | Maximum Recommended Daily Dose: | 0.496 |
Skin Sensitization: | 0.876 | Carcinogencity: | 0.028 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.01 |
Respiratory Toxicity: | 0.781 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003647 | ![]() |
0.842 | D0B1FE | ![]() |
0.307 | ||
ENC002868 | ![]() |
0.692 | D0DV3O | ![]() |
0.306 | ||
ENC000977 | ![]() |
0.644 | D07VHR | ![]() |
0.302 | ||
ENC001948 | ![]() |
0.633 | D08FTG | ![]() |
0.301 | ||
ENC003203 | ![]() |
0.527 | D0QL3P | ![]() |
0.299 | ||
ENC004162 | ![]() |
0.522 | D0QV5T | ![]() |
0.295 | ||
ENC002127 | ![]() |
0.471 | D0E3OF | ![]() |
0.293 | ||
ENC002409 | ![]() |
0.463 | D04QZD | ![]() |
0.287 | ||
ENC003601 | ![]() |
0.398 | D04BNP | ![]() |
0.286 | ||
ENC002940 | ![]() |
0.387 | D0R6RO | ![]() |
0.286 |